|
|
CN
Online Message×
Click switch

ContainmedicilonContent

Jan 04,2022
Sincere Collaboration, New and Far-Reaching - Bao Pharmaceutical and Medicilon reached a strategic collaboration
On December 17, 2021, Shanghai Bao Pharmaceutical Co., Ltd. (Bao) and Shanghai Medicilon Inc. (Medicilon) signed an innovative drug IND R&D service strategy collaboration agreement.
More
Jan 04,2022
Medicilon Bacterial Endotoxin Testing Solutions
Bacterial Endotoxin Test Procedure Bacterial endotoxin method development (sample volume 3 bottles/batch, one batch) Bacterial endotoxin method verification (sample volume 3 bottles/batch, three batches) Bacterial endotoxin test (sample volume 3 bottles/batch, three batches) Bacterial endotoxin is one of the components of the cell wall of Gram-negative bacteria: LPS Released after the bacteria die Bacterial endotoxinRead more
More
Jan 04,2022
With its strength on the list, Medicilon was successfully identified as the "Shanghai Enterprise Technology Center"
On December 9th, the publicity of the list of recognized municipal enterprise technology centers in Shanghai for 2021 (the 27th batch) was completed. Medicilon was recognized as the "Shanghai Enterprise Technology Center" with its solid R&D capabilities and technological innovation capabilities.
More
Nov 29,2021
Biacore Analysis of Medicilon
As a high-throughput test system, Biacore 8K can help customers analyze a large number of samples in a short period of time. Biacore™ 8K can complete the screening, affinity and kinetic characterization of small molecule compound drugs and biotherapeutics at the speed you dream of, and provide the high-quality data you expect. As a newRead more
More
Nov 29,2021
SeMet-labeled Protein High-yield Expression Medium
Selenium has been recognized by the World Health Organization as an essential trace element for the human body. It has strong anti-tumor and immunity enhancement effects. Compared with inorganic selenium, organic selenium has low toxicity, high bioavailability, and strong pharmacological activity. Selenomethionine is a natural organic selenium product with very few sources. Therefore, preparation byRead more
More
Oct 25,2021
Medicilon Symposium – “Preclinical Development Strategy of Innovative Drugs Driven by Translational Medicine” was Successfully Held
The 4th Annual Precision Medicine and Immuno-Oncology China Summit 2021 (PMIO China 2021) was successfully held in Zhangjiang, Shanghai recently.  Shanghai Medicilon Inc. (Medicilon) and
More
Oct 25,2021
Medicilon was Awarded The “Golden Horse Award-2021 Best Preclinical CRO/CDMO Enterprise”
From October 19-21, 2021, a grand event that has attracted the attention of the national pharmaceutical industry, “2021 Nanjing International Summit on Innovation and Investment
More
Oct 18,2021
Mr. Guolin Wang, Director and Secretary of the Board of Medicilon, won another award!
Recently, the selection of 2021 elite board secretaries of the Cai Lian She (CLS) and the Night of Qingdao Board Secretaries were held in Haitian
More
Jan 11,2022
Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use
On December 28, 2021, Hangzhou DAC Biotechnology Co., Ltd. (DAC Biotech) DXC007 project was successfully approved for clinical trials. DXC007 is the fourth ADC drug approved for clinical use by DAC Biotech, and it is also the fourth ADC drug that Shanghai Medicilon Inc. (Medicilon) to help DAC Biotech successfully getting approval.
More
Jan 11,2022
Medicilon Assisted Regor Therapeutics Group's New-generation Tumor-targeting Inhibitor RGT-419B Getting Approved for Clinical Use
On December 28, 2021, the new generation of CDK2/4/6 small molecule inhibitor RGT-419B independently developed by Regor Therapeutics Group (Regor) was approved by the U.S. Food and Drug Administration (FDA).
More
Jan 07,2022
Join Medicilon at Precision in Drug Discovery & Preclinical 2022 Summit

DATE: Sep 28-29, 2022

LOCATION: Frankfurt, Germany (Europe)

More
Jan 04,2022
Recording the Growth of Medicilon in 2021
This year, Medicilon, with persistent belief, courageously and innovatively, pursued quality, and gave birth to the power of joint growth. Today, we take you to review the 2021 and witness the growth and progress of Medicilon!
More
Nov 24,2021
Two Innovative Service Platforms of Medicilon were Selected as
Recently, the “2021 Yangpu Service Trade Digital Transformation Forum” under the guidance of the Shanghai Municipal Commission of Commerce and the People’s Government of Yangpu
More
Nov 24,2021
Medicilon is Included in the MSCI China Index!
On the November 12th, the international index compilation company MSCI announced the results of the November quarterly index review.  Shanghai Medicilon Inc. (stock code: 688202.SH)
More
Oct 18,2021
The Internationalization Trend of Chinese Pharmaceutical Companies and AI R&D Innovation Forum
Two forum themes, an inaugural meeting of Zhangjiang AI New Drug R&D Alliance Establishment, three keynote speeches, three rounds of roundtable discussion, a gathering of
More
Oct 12,2021
Join Medicilon at the AAPS 2021 PharmSci 360
Medicilon is looking forward to meeting you at this year’s American Association of Pharmaceutical Scientists (AAPS) annual meeting—“PharmSci 360″. PharmSci 360 is an in-person meeting + virtual
More
Jan 19,2022
Medicilon MPTP Parkinson Disease Model
Medicilon has effective models for evaluating new drugs for Parkinson, including MPTP-induced mouse subacute PD model, MPTP+ probenecid-induced mouse chronic PD model, oxytremorine-induced cholinergic symptom model, etc.
More
Jan 18,2022
In Vivo Tumor Models
Medicilon boasts nearly 300 in vivo tumor models. At the same time, we are empowering innovative therapies to comprehensively evaluate and study immuno-oncology.
More
Jan 14,2022
Commonly Used Mouse and Nude Mouse Tumor Model
In animal tumor transplantation models, Kunming mice or purebred mice are often used to inoc-ulate mouse tumors, and the inhibitory effect of the test substance on tumor growth is observed.
More
Jan 11,2022
Nude Mice Animal Model
Nude mice are immunodeficient animals because they have no thymus glands, so they lack immune response. Medicilon Pharmacology Service provides you with experiments on tumor formation in nude mice and subcutaneous tumor formation in nude mice.
More